The short version of albumin binding fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2026-06-23. Anything still debated is marked as such rather than presented as settled.
Tirzepatide is a synthetic peptide of 39 amino acids engineered from the native glucose-dependent insulinotropic polypeptide sequence. Its structure incorporates several non-natural residues and a C-terminal segment derived from glucagon-like peptide-1, together with a C20 fatty diacid moiety attached through a linker. The lipophilic side chain promotes binding to serum albumin, which slows renal clearance after administration. The compound is classified as a dual incretin receptor agonist and is supplied as a lyophilized powder for reconstitution or as a preformulated solution, depending on the presentation.
The peptide activates two G protein-coupled receptors, GIPR and GLP-1R. Binding triggers adenylyl cyclase activity and raises intracellular cyclic AMP in pancreatic beta cells, which potentiates insulin release when glucose is elevated. Signaling in the central nervous system is associated with reduced appetite and lower energy intake, while effects on gastric emptying and glucagon secretion are also reported. Because activity at both receptors is retained, the pharmacological profile is often described as incretin-based rather than selective for a single receptor.
Peptide active ingredients of this type are typically supplied as lyophilized powder because the dry form resists hydrolysis during transport. The material is hygroscopic, so vials are usually equilibrated to room temperature before opening to avoid condensation on the solid. Repeated freeze-thaw cycles can promote aggregation and are generally avoided by aliquoting stock into single-use portions. Personnel handling the powder work in controlled environments to limit inhalation of fine particles. Written procedures usually specify these steps rather than leaving them to individual judgment.
Long-term storage of the solid generally relies on temperatures at or below minus twenty degrees Celsius, while short-term working stocks may be held refrigerated. Light exposure is limited because photodegradation can alter side chains over extended periods. Solutions prepared for analysis are less stable than the dry powder and are typically used within the same working day. Buffer choice matters, since some aqueous conditions favor deamidation or oxidation at specific residues. Stability data are usually generated under defined accelerated conditions and then extrapolated with stated assumptions.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C225H348N48O68 | Approximate composition of the free peptide |
| Molecular weight | Approximately 4813 Da | Calculated for the free base |
| Structural class | Synthetic linear peptide | 39 residues with modified backbone |
| Solubility | Soluble in water and polar solvents | Behavior of the lyophilized solid |
| Typical storage temperature | -20 degrees Celsius or below | Solid form, protected from light |
Dual agonism at the GIP and GLP-1 receptors underlies the observed pharmacology. Activation of GLP-1 receptors raises glucose-dependent insulin release, lowers glucagon secretion, slows gastric emptying and reduces appetite. GIP receptor activation contributes additional effects on adipose tissue and on energy balance, and the combined action on appetite appears larger than either pathway alone in animal models. Signalling bias and the relative contribution of each receptor arm to weight-related effects remain areas of active investigation.
Structure-activity work shows that fatty acid length, linker chemistry and the position of acylation all influence albumin affinity and receptor potency. Plasma protein binding exceeds 99 percent, which restricts distribution and slows renal clearance. Degradation proceeds largely through general proteolysis and fatty acid oxidation rather than cytochrome P450 metabolism, so exposure to common oxidative drug interactions is limited. Whether these clearance routes vary meaningfully between individuals is not fully established.
Tirzepatide is a synthetic peptide composed of 39 amino acids. It acts as a dual agonist at two incretin receptors, the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor. The molecule was designed by modifying the native sequence of glucose-dependent insulinotropic polypeptide to improve metabolic stability and extend its circulation time. Its structure includes several non-natural amino acid residues and a fatty acid side chain. These features distinguish it from earlier single-receptor incretin analogs studied in the same period.
The compound first appeared in the scientific literature as an investigational agent for type 2 diabetes. Clinical development proceeded through phase 1, phase 2, and phase 3 programs that measured glycemic control as a primary endpoint while recording body weight as a secondary outcome. Regulatory approval in the United States followed in 2022 for glycemic control, and a separate indication for chronic weight management was added later. Subsequent trials have examined cardiovascular outcomes in adults with elevated cardiovascular risk. Debates continue over how much of the observed effect derives from each receptor arm.
Structural work on the molecule centers on a C20 fatty diacid moiety attached through a linker to the peptide backbone. This side chain promotes reversible binding to serum albumin, which slows renal clearance and supports a prolonged action profile. The peptide backbone incorporates aminoisobutyric acid substitutions that limit recognition by digestive enzymes. Together these modifications produce a molecule that is stable enough for subcutaneous delivery but still dependent on careful manufacturing control. Analytical characterization of the active pharmaceutical ingredient typically follows the conventions used for other synthetic peptides.
== External links == Elastin at the U.S. National Library of Medicine Medical Subject Headings (MeSH) Histology image: 21402loa – Histology Learning System at Boston University GeneReviews/NIH/NCBI/UW entry on Williams or Williams-Beuren Syndrome The Elastin Protein Microfibril This article incorporates text from the United States National Library of Medicine, which is in the public domain.
=== Emergence of the Israelite culture === Efforts to confirm the biblical ethnogenesis of Israel through archaeology have largely been abandoned as unfruitful. Many scholars see the traditional narratives as national myths with little historical value, but some posit that a small group of exiled Egyptians contributed to the Exodus narrative. William G. Dever cautiously identifies this group with the Tribe of Joseph, while Richard Elliott Friedman identifies it with the Tribe of Levi. Josephus quoting Manetho identifies them with the Hyksos. Other scholars believe that the Exodus narrative was a "collective memory" of several events from the Bronze Age.
http://www.rxlist.com/cgi/generic3/oprelvek.htm Archived 2008-08-30 at the Wayback Machine http://www.wyeth.com/products_hcp?product=/wyeth_html/home/products/prescription/Neumega®%20(oprelvekin)/Neumega®%20(oprelvekin)_overview.html Archived 2008-01-18 at the Wayback Machine (Drug Information provided by Wyeth)
Sources: en.wikipedia.org
== History == In the late 19th century, most vacuums were created using a Sprengel pump, which had the advantage of being very simple to operate, and capable of achieving quite good vacuum given enough time. Compared to later pumps, however, the pumping speed was very slow and the vapor pressure of the liquid mercury limited the ultimate vacuum. Following his invention of the molecular pump, Wolfgang Gaede invented the diffusion pump in 1915, and originally used elemental mercury as the working fluid. After its invention, the design was quickly commercialized by Leybold. It was then improved by Irving Langmuir, and W. Crawford. C.R. Burch described the possibility of using silicone oil in 1928.
Justice Secretary Alex Chalk announces that prisons in England and Wales will be allowed to release some minor offenders on probation early in order to alleviate overcrowding. 17 October Data from the Office for National Statistics indicates average wages increased by 7.8% in the three months July 2023, and consequently outpaced inflation for the first time since October 2021. Wales becomes the first country in the UK to ban the use of snares and glue boards for catching rats. 18 October Amazon announce plans to begin using drones to deliver packages in the UK by the end of 2024. The High Court releases its ruling over the Carla Foster case, stating that sentencing women to prison for abortion related crimes is "unlikely" to be a "just outcome". 19 October Prime Minister Rishi Sunak begins a two-day visit to Israel as part of diplomatic efforts to help prevent the Israel–Hamas war escalating into a wider Middle East conflict. Following a meeting with Israeli prime minister Benjamin Netanyahu, Sunak says he will stand with Israel "in solidarity". British-Israeli Yonatan Rapoport is named as one of the people killed during the 7 October attack on Israel. Migrants are returned to the Bibby Stockholm accommodation barge in Portland, Dorset, amid protests at the port gates. Members of the National Union of Rail, Maritime and Transport Workers (RMT) vote to stage a further six months of strike action.
== History == In 1822 the first awards were given to thirteen people by the Philadelphia Society for Promoting Agriculture entrusted by the "Corporation of the city of Philadelphia". The druggist John Scott of Edinburgh organized a $4,000 fund which, after his death in 1815 was administered by a merchant until the first award, a copper medal and "an amount not to exceed twenty dollars", was given in 1822. (At the time, $20 could buy one ox or a 12-volume encyclopedia.) Several hundred recipients have since been selected by the City Council of Philadelphia, which decides from the annual list of nominees made by the Franklin Institute.
=== March === 1 March – First Minister Humza Yousaf announces that his wife, Nadia El-Nakla, is expecting a baby in July, making him the first Scottish First Minister to become a parent while in office. 7 March – The Scottish Government announces an independent public inquiry into the police handling of the Emma Caldwell murder investigation. Police Scotland announces it will no longer investigate every low level crime following the success of a pilot project. 8 March – The creators of Wirdle, a Shetland dialect version of the Wordle game, announce the game's withdrawal following legal threats from The New York Times, owners of the original game. 9 March – A Daily Telegraph report alleging a conflict-of-interest involving First Minister Humza Yousaf after the Scottish Government donated £250,000 to the UN agency UNRWA, which supports Palestinian refugees, is rejected by Yousaf as an "outrageous smear" and a "far right conspiracy". 10 March – The Duke of Edinburgh is awarded the Order of the Thistle by Charles III, Scotland's highest royal honour. Creative Scotland launches an investigation into a decision to provide nearly £85,000 of public money for an arts project involving "hardcore" sex performances. 11 March – The driver of a double decker bus is arrested after the vehicle's roof is ripped off after crashing into a railway bridge in West Lothian. No passengers were aboard the bus at the time. 12 March – Professor Jason Leitch announces he will leave his role as National Clinical Director at the end of April.
Sources: en.wikipedia.org
It is a synthetic linear peptide that acts as a dual agonist at the GIP and GLP-1 receptors. It combines a modified incretin backbone with a fatty diacid side chain that extends its circulation time. It is not a small-molecule drug and is not orally absorbed in its native form.
Single-receptor agents act predominantly at GLP-1R. Tirzepatide retains activity at GIPR, which is expressed in pancreatic islets, adipose tissue, and the central nervous system. The contribution of each receptor to the overall response is still an area of active study, and the relative weight of GIPR signaling in humans is not fully settled.
The fatty diacid moiety binds serum albumin, which reduces renal filtration of the active peptide. Additional resistance to enzymatic breakdown comes from non-natural residues in the backbone. Together these features produce an apparent half-life of about five days and permit weekly dosing intervals.
Water promotes hydrolysis and deamidation, so removing it slows degradation during transport and storage. The dry solid is also less prone to microbial growth than a solution. Reconstitution is therefore performed close to the point of use.